J&J enters deal with Second Genome to study gut bacteria

 
• By Brett Chase

Johnson & Johnson partnered with a startup company to study gut bacteria in hopes of developing drugs for bowel disease.

More from Alimentary/Metabolic

More from Therapeutic Category